Cite
HARVARD Citation
Ciampi, E. et al. (2017). Grey matter atrophy is associated with disability increase in natalizumab-treated patients. Multiple sclerosis. pp. 556-566. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ciampi, E. et al. (2017). Grey matter atrophy is associated with disability increase in natalizumab-treated patients. Multiple sclerosis. pp. 556-566. [Online].